Bristol-Myers Squibb To Buy Amylin Pharma For $5.3 BlnReported by FinanzNachrichten.de on Saturday, 30 June 2012 (on June 30, 2012)
LONDON (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) has agreed to acquire Amylin Pharmaceuticals, Inc. (AMLN) for $31 per share in cash, pursuant to a cash tender offer and second step me...
Links: Full news story
|Recent related news|
|No similar news headlines found.|